FAK protein linked to chemotherapy resistance in ovarian cancer

A new study links changes in the gene for the protein focal adhesion kinase, or FAK, to ovarian cancer's ability to survive chemotherapy.

from Women's Health News -- ScienceDaily https://ift.tt/2NUax06

Vitamin D: How much is too much of a good thing?

A three-year study has shown that there is no benefit in taking high doses of vitamin D. More research is required to determine if high doses may actually compromise bone health.

from Women's Health News -- ScienceDaily https://ift.tt/2NO85sj

Breast cancer gene a potential target for childhood liver cancer treatment

Hepatoblastoma is a rare liver cancer that mainly affects infants and young children. Researchers confirmed that breast cancer gene GREB1 plays a major role in hepatoblastoma cell proliferation. By interfering with GREB1 protein production, tumor formation was inhibited in a mouse liver cancer model, suggesting this approach could be used to develop a targeted hepatoblastoma therapy.

from Breast Cancer News -- ScienceDaily https://ift.tt/2HHs87N

Breast cancer can form 'sleeper cells' after drug treatment

Breast cancer medicines may force some cancer cells into 'sleeper mode,' allowing them to potentially come back to life years after initial treatment.

from Women's Health News -- ScienceDaily https://ift.tt/2ZuXz06

Breast cancer can form 'sleeper cells' after drug treatment

Breast cancer medicines may force some cancer cells into 'sleeper mode,' allowing them to potentially come back to life years after initial treatment.

from Women's Health News -- ScienceDaily https://ift.tt/2ZuXz06

Breast cancer can form 'sleeper cells' after drug treatment

Breast cancer medicines may force some cancer cells into 'sleeper mode,' allowing them to potentially come back to life years after initial treatment.

from Breast Cancer News -- ScienceDaily https://ift.tt/2ZuXz06

Menopausal hormone therapy and breast cancer incidence

New research suggest that all types of MHT, except topical vaginal estrogens, are associated with increased risks of breast cancer, and that the risks are greater for users of estrogen-progestagen hormone therapy than for estrogen-only hormone therapy. For estrogen-progestagen therapy, the risks were greater if the progestagen was included daily rather than intermittently (eg, for 10-14 days per month).

from Breast Cancer News -- ScienceDaily https://ift.tt/2ZFZvOm

Menopausal hormone therapy and breast cancer incidence

New research suggest that all types of MHT, except topical vaginal estrogens, are associated with increased risks of breast cancer, and that the risks are greater for users of estrogen-progestagen hormone therapy than for estrogen-only hormone therapy. For estrogen-progestagen therapy, the risks were greater if the progestagen was included daily rather than intermittently (eg, for 10-14 days per month).

from Women's Health News -- ScienceDaily https://ift.tt/2ZFZvOm

Menopausal hormone therapy and breast cancer incidence

New research suggest that all types of MHT, except topical vaginal estrogens, are associated with increased risks of breast cancer, and that the risks are greater for users of estrogen-progestagen hormone therapy than for estrogen-only hormone therapy. For estrogen-progestagen therapy, the risks were greater if the progestagen was included daily rather than intermittently (eg, for 10-14 days per month).

from Women's Health News -- ScienceDaily https://ift.tt/2ZFZvOm

Waist size, not body mass index, may be more predictive of coronary artery disease

For years, women have been told that weight gain could lead to heart disease. A new study indicates that it is the location of the fat that matters most, with abdominal fat representing the greatest harm and not overall body mass index (BMI) when assessing risk for coronary artery disease (CAD).

from Women's Health News -- ScienceDaily https://ift.tt/2PjpDyV